BACKGROUND: Many Canadians known to have hypertension remain untreated. To aid in the development of specific programs to improve hypertension management, the present report characterizes Canadians who indicated that they had hypertension but were not taking antihypertensive drug therapy. METHODS: The 2005 Canadian Community Health Survey (cycle 3.1) was used to estimate the proportion of Canadians 20 years of age and older who reported having high blood pressure or ever being diagnosed with high blood pressure. Sociodemographic characteristics, reported health, lifestyle factors and health care resource use of those who reported taking or not taking high blood pressure medication in the previous month were described and compared. RESULTS: Over one-half of hypertensive respondents 20 to 39 years of age reported no antihypertensive treatment compared with 17% and 5% among those 40 to 59 years and 60 years of age and older, respectively. In most age groups, several factors were associated with the absence of pharmacotherapy (eg, male sex, fewer health care professional consultations, perceived excellent health status and most markers of lower cardiovascular risk, with the exception of daily smoking). The proportion of young hypertensive Canadians not receiving pharmacotherapy remained consistent, regardless of the presence of cardiovascular risk factors. CONCLUSIONS: Many hypertensive Canadians, particularly those who are younger than 60 years of age, are not taking antihypertensive drug therapy despite having one or more cardiovascular risks. The increased risk of no drug therapy among smokers warrants special attention.
BACKGROUND: Many Canadians known to have hypertension remain untreated. To aid in the development of specific programs to improve hypertension management, the present report characterizes Canadians who indicated that they had hypertension but were not taking antihypertensive drug therapy. METHODS: The 2005 Canadian Community Health Survey (cycle 3.1) was used to estimate the proportion of Canadians 20 years of age and older who reported having high blood pressure or ever being diagnosed with high blood pressure. Sociodemographic characteristics, reported health, lifestyle factors and health care resource use of those who reported taking or not taking high blood pressure medication in the previous month were described and compared. RESULTS: Over one-half of hypertensive respondents 20 to 39 years of age reported no antihypertensive treatment compared with 17% and 5% among those 40 to 59 years and 60 years of age and older, respectively. In most age groups, several factors were associated with the absence of pharmacotherapy (eg, male sex, fewer health care professional consultations, perceived excellent health status and most markers of lower cardiovascular risk, with the exception of daily smoking). The proportion of young hypertensive Canadians not receiving pharmacotherapy remained consistent, regardless of the presence of cardiovascular risk factors. CONCLUSIONS: Many hypertensive Canadians, particularly those who are younger than 60 years of age, are not taking antihypertensive drug therapy despite having one or more cardiovascular risks. The increased risk of no drug therapy among smokers warrants special attention.
Authors: S C Smith; S N Blair; M H Criqui; G F Fletcher; V Fuster; B J Gersh; A M Gotto; K L Gould; P Greenland; S M Grundy Journal: Circulation Date: 1995-07-01 Impact factor: 29.690
Authors: Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy Journal: JAMA Date: 2002-02-27 Impact factor: 56.272
Authors: Norman R C Campbell; Finlay A McAlister; Rollin Brant; Mitch Levine; Denis Drouin; Ross Feldman; Robert Herman; Kelly Zarnke Journal: J Hypertens Date: 2003-08 Impact factor: 4.844
Authors: Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Christina M Bancej; Norm Campbell; Donald W McKay; Marianne Nichol; Robin L Walker; Janusz Kaczorowski Journal: Can J Cardiol Date: 2010-05 Impact factor: 5.223
Authors: Aaron K Ho; Christie M Bartels; Carolyn T Thorpe; Nancy Pandhi; Maureen A Smith; Heather M Johnson Journal: Am J Hypertens Date: 2016-02-24 Impact factor: 2.689
Authors: Aaron K Ho; Carolyn T Thorpe; Nancy Pandhi; Mari Palta; Maureen A Smith; Heather M Johnson Journal: J Hypertens Date: 2015-11 Impact factor: 4.844
Authors: Heather M Johnson; Carolyn T Thorpe; Christie M Bartels; Jessica R Schumacher; Mari Palta; Nancy Pandhi; Ann M Sheehy; Maureen A Smith Journal: J Gen Intern Med Date: 2014-02-04 Impact factor: 5.128